BRK.A arrives at Tuesday's Q2 release having gained further ground since the last preview — closing at $780,086 on August 7, up 1.7% on the week and 3.2% over the past month — and the stock remains above the Street's mean price target of $764,712.
That gap between price and consensus is the defining tension in this setup. Nothing in the lending market complicates the picture: short interest has edged up roughly 2.8% on the week to around 189 shares, but remains negligible in absolute terms. Availability is effectively unlimited, the cost to borrow has fallen to 0.11%, and the ORTEX short score of 26.4 ranks in the 90th percentile for low short pressure. There is no speculative pressure on either side of the trade. The earnings report will be read on its own merits.
The analyst debate has a clear shape. UBS's Brian Meredith raised his target to $877,848 on July 28 — the most recent move from the only active covering analyst — maintaining his Buy and implying roughly 13% further upside from current levels. Keefe Bruyette holds an Underperform at $695,000, a note that dates from November 2025 and now sits nearly 11% below where the stock trades. The consensus mean at $764,712 is itself below the current price, which is an unusual configuration: it means the stock has outrun the aggregate view, and a Q2 beat on operating earnings or a notable change in Berkshire's cash deployment posture would be needed to pull that mean target higher. The valuation picture adds some texture — the price-to-book ratio has drifted up to 1.49, its highest reading over the past month, while the P/E of 25x has also ticked higher. Neither level is extreme for Berkshire, but both reinforce that the stock is priced for continued execution rather than any discount.
Warren Buffett's reported stake remains the largest single block at around 13% of shares, with a modest reduction of 8,025 shares in the most recently filed period. The institutional base is otherwise stable, with BlackRock and State Street both adding small positions through July. CEO Greg Abel's cluster of purchases in early March — totalling roughly $15.3 million across ten transactions at prices near $727,000–$733,000 — represents the last meaningful insider signal, and the stock has since appreciated past those entry levels.
Tuesday's print is therefore a test of whether Berkshire's operating businesses — insurance float, energy, and manufacturing — delivered the earnings growth needed to validate a stock that has already run past what the broader analyst community thought it was worth.
See the live data behind this article on ORTEX.
Open BRK.A on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
